Hiv's No. 1 Enemy

Protease inhibitors, taken with other drugs, have made the greatest inroads against AIDS. In some patients, HIV is so diminished as to be undetectable. Three are on the market--including Merck's CRIXIVAN, shown here--with others on the way.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.